Latest News
Johnson & Johnson's DARZALEX FASPRO receives US FDA approval
7 November 2025 - Healthcare products company Johnson & Johnson (J&J) (NYSE:JNJ) announced on Thursday that it has received approval from the US Food and Drug Administration (FDA) for DARZALEX FASPRO (daratumumab and hyaluronidase-fihj) as a ...
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
7 November 2025 - PharmaJet®, a leader in needle-free drug delivery systems designed to improve outcomes and patient comfort, has confirmed a new Distribution Agreement with ATR, an affiliate company of EVA Pharma. EVA Pharma is widely recognised...
10XREVIV Launch Announced in Abu Dhabi Through Partnership Between 10X Health, REVIV Global and M42
6 November 2025 - 10X Health in the United States and REVIV Global in the United Kingdom have entered into a strategic partnership with Abu Dhabi–based global health leader M42 to launch 10XREVIV, introducing a Precision Nutrition System to the...
HanchorBio to present HCB301 preclinical data at Society for Immunotherapy of Cancer's 40th Annual Meeting
6 November 2025 - HanchorBio Inc (TPEx:7827), a Taiwan-based global clinical-stage biotechnology company, announced on Wednesday that it will present preclinical data on HCB301, a novel tri-specific immunotherapeutic fusion protein, at the 40th Annua...
Calico Life Sciences' ABBV-CLS-628S granted US FDA Orphan Drug Designation
6 November 2025 - Calico Life Sciences LLC, a biotechnology company focused on ageing and age-related diseases, founded by Alphabet Inc (NASDAQ:GOOG) and Arthur D. Levinson, announced on Wednesday that it has received Orphan Drug Designation (ODD) fr...